Rare Disease Day takes place annually on the last day of February. Rare Disease Day’s goal is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on patients. Warren Center researchers have a rich history in rare disease therapeutic research and a few examples are summarized below.…
As the celebration of the sesquicentennial of science comes to a close and the one-year anniversary of Rev. Theodore M. Hesburgh, C.S.C.’s passing approaches, the University of Notre Dame reflects on the life of Father Hesburgh and his impact on the growth and development of the sciences and scientific research at the University during his tenure and beyond.
During the one year anniversary of the death of Fr. Hesburgh, the College of Science recalls and appreciates the impact that he had on science at Notre Dame.
Paul W. Bohn, the Arthur J. Schmitt Professor of Chemical and Biomolecular Engineering and concurrent professor of chemistry and biochemistry, has been appointed to the editorship of Annual Reviews of Analytical Chemistry, the most highly cited publication in the field. Bohn, who has served four years on the journal’s international board, will serve a four-year term as co-editor.
Prashant Kamat, the Rev. John A. Zahm Professor of Science in the Department of Chemistry and Biochemistry and Radiation Laboratory at the University of Notre Dame, will serve as the inaugural editor-in-chief of ACS Energy Letters, a new peer-reviewed journal from the American Chemical Society (ACS). ACS Letters will enable the rapid publication of advances in energy research.
Bradley Smith, Emil T. Hofman Professor of Chemistry & Biochemistry and a researcher in the Warren Family Research Center for Drug Discovery and Development, from the Molecular Therapeutics Program of the Indiana CTSI for a project entitled “Novel Drug Candidates for Treating Leishmaniasis.” The work will be carried out in collaboration with Miguel Morales, Assistant Professor of Biological Sciences, and a member of the Eck Institute for Global Heath.
Notre Dame’s Richard Taylor, Interim Director of the Warren Family Research Center for Drug Discovery and Development and Professor of Chemistry & Biochemistry has been selected to participate in a National Institutes of Health training program, “Neurotherapeutics Discovery and Development for Academic Scientists.” In addition to fundamental principles of discovery, development, and IND enabling studies, the course will also address the unique challenges inherent in developing treatments for nervous system disorders.
Thursday (Feb. 4) marks World Cancer Day. World Cancer Day was established by the Paris Charter adopted at the World Summit Against Cancer for the New Millennium in Paris on Feb. 4, 2000. The goals of the charter are the promotion of research to cure as well as prevent the disease, upgrades to the provided services to the patients, the sensitization of the common opinion and the mobilization of the global community against cancer.
Five University of Notre Dame faculty members — Bertrand Hochwald and J. Nicholas Laneman from the College of Engineering, Timothy Beers and Prashant Kamat from the College of Science, and Luis Gómez-Mejia from the Mendoza College of Business — have been named to the 2015 Thomson Reuters’ Highly Cited Researchers list. The list identifies the top 1 percent of the almost 9 million scholars and scientists who publish their academic findings every year, accounting for more than 2 million journal papers.
Zachary Schultz, Associate Professor of Chemistry and Biochemistry, has accepted an invitation to join the Features Panel of the journal Analytical Chemistry. This appointment is for a three-year term beginning in 2016.
Travis Marshall-Roth (’15) has been selected as the winner of the 2016 American Chemical Society Division of Inorganic Chemistry Award for Undergraduate Research for students at research universities. Marshall-Roth and his research advisor Seth Brown, professor of chemistry and biochemistry, were recognized for their work elucidating the reaction mechanism for non-classical oxygen atom transfers and developing new catalyst designs with multiple redox-active ligands.
The Notre Dame Initiative for Global Development (NDIGD) and Professor Marya Lieberman have won a USAID Development Innovation Ventures award to improve global health.
The Warren Family Research Center for Drug Discovery and Development at the University of Notre Dame has established a research collaboration with Retrophin, Inc. and the Grace Wilsey Foundation to focus on developing treatment for NGLY1 deficiency. …
Amanda Hummon, the Husking Foundation, Inc. Associate Professor of Chemistry and Biochemistry, has received a 2016 Rising Star Award from the American Chemical Society’s Women Chemists Committee. Hummon will accept the award at the national American Chemical Society (ACS) meeting in San Diego in March.
Notre Dame researchers led by Ken Henderson have achieved a critical step in the search for rapid molecular-based computing. The group demonstrated the ability to move an electron within a neutral molecule, providing the binary switch necessary for computing. A key advance is that the molecule does not require the presence of a second molecule to generate the electron, which creates bias in the system.
University of Notre Dame faculty members — Timothy Beers and Prashant Kamat from the College of Science and Bertrand Hochwald and J. Nicholas Laneman from the College of Engineering and — have been named to the Thomson Reuters’ list of Highly Cited Researchers for 2015. Hochwald, Beers, and Kamat were named in the 2014 list. All four faculty members have also appeared on previous years’ lists.
The University of Notre Dame has received $133.7 million in research funding for fiscal year 2015. This is an all-time record for the University and $20 million more than last year.
Professor Marya Lieberman has been awarded a grant from the US Agency for International Development (USAID) to monitor the quality of pharmaceuticals across western Kenya through the use of innovative diagnostic test cards developed in her laboratory. These inexpensive, point-of-need devices have been shown to detect falsified antibiotics, TB medications, and anti-malarial drugs.